CTA
RARX

Carillon Tower Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-693,726
Closed -$16.4M 495
2019
Q3
$16.4M Buy
693,726
+127,606
+23% +$3.02M 0.11% 276
2019
Q2
$17M Buy
+566,120
New +$17M 0.12% 271